SI
ETTX

Sofinnova Investments’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Sofinnova Investments’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,012,408
Closed -$2.06M – 86
2020
Q3 		$2.06M Sell
1,012,408
-167,770
-14% -$479K 0.15% 60
2020
Q2 		$3.49M Hold
1,180,178
– – 0.22% 59
2020
Q1 		$3.12M Hold
1,180,178
– – 0.29% 45
2019
Q4 		$5.87M Hold
1,180,178
– – 0.42% 40
2019
Q3 		$7.03M Hold
1,180,178
– – 0.64% 35
2019
Q2 		$7.61M Hold
1,180,178
– – 0.7% 33
2019
Q1 		$7.97M Hold
1,180,178
– – 0.77% 26
2018
Q4 		$4.8M Hold
1,180,178
– – 0.6% 34
2018
Q3 		$12.8M Buy
+1,180,178
New +$12.4M 1.14% 18

Other funds holding ETTX

PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Sofinnova Investments's ETTX Position: Q4 2020 in Review

Sofinnova Investments sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q4 2020, closing a stake of 1,012,408 shares — an estimated $2.06M sold.

Sofinnova Investments first reported a position in ETTX in Q3 2018 and held it in 9 quarters. The position peaked at $12.8M in Q3 2018. 25 funds tracked by Wall St. Rank hold ETTX as of Q4 2020.

  • Sofinnova Investments reported no remaining Entasis Therapeutics Holdings Inc. position as of Q4 2020 after selling out during the quarter.
  • Sofinnova Investments sold 1,012,408 Entasis Therapeutics Holdings Inc. shares in Q4 2020, an estimated $2.06M.
  • Sofinnova Investments first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2018 and held it in 9 quarters.
  • Sofinnova Investments's Entasis Therapeutics Holdings Inc. position peaked at $12.8M in Q3 2018.
  • 25 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q4 2020.

Based on Sofinnova Investments's 13F filing for Q4 2020, filed 16 Feb 2021.